Amyris, Inc., which owns consumer brands like Biossance and Pipette and is a supplier of natural ingredients, today announced financial results for its second quarter ended June 30, 2021.   Total revenue of $52.3 million included record underlying and consumer revenue and included $10 million of proceeds resulting from the Reb M sweetener transaction. Total underlying revenue (product and collaboration revenue) increased 41% to $42.3 million compared to Q2 2020 revenue. It was driven by a 59% ...